Iris Dorbian

Univercells rakes in $18.8 mln Series B

Univercells SA, a Belgian biotech company, has raised $18.8 million in Series B funding. Global Health Investment Fund led the round.

Golden Equator and Korea Investments targets $88 mln for Asia tech startups fund: Bloomberg

Golden Equator Capital and Korea Investments Partners are seeking to raise $88 million for a joint fund, according to Bloomberg. The fund will invest in tech startups in Asia. The fund is reportedly targeting a final close by the end of the year, reported the news outlet.

PPRO Group fetches $50 mln

UK-based PPRO Group, a provider of cross-border e-payment solutions, has raised $50 million in funding. PayPal led the round with participation from Citi Ventures and return backer HPE Growth Capital.

Undo lands $14 mln Series B

UK-based Undo, a developer of new software debugging technologies, has raised $14 million in Series B funding. Cambridge Innovation Capital plc led the round.

Pliant Therapeutics snags $62 mln Series B

South San Francisco-based Pliant Therapeutics Inc, a biotech firm, has raised $62 million in Series B financing. Cowen Healthcare Investments led the round with participation from other investors that included Eventide Asset Management, Schroder Adveq, Menlo Ventures, SCubed Capital and Agent Capital.

High Alpha racks up over $100 mln

Indianapolis-based High Alpha, a venture studio, has raised over $100 million in funding. High Alpha Studio II, an enterprise cloud startup studio, has secured $16.65 million from repeat investor Emergence Capital and Foundry Group. Also, High Alpha Capital, a seed and Series A venture fund, has closed its High Alpha Capital II at $85 million.

RSE Ventures backs Australian lifestyle and hospitality brand Bluestone Lane

RSE Ventures has made an investment in Bluestone Lane, an Australian lifestyle and hospitality brand. No financial terms were disclosed.

Paidy Inc amasses $55 mln Series C

Paidy Inc, an instant post-pay credit service for ecommerce consumers in Japan, has raised $55 million in Series C funding. ITOCHU Corporation led the round with participation from Goldman Sachs.

Floret Ventures targets $25 mln for fund

Floret Ventures is seeking to raise $25 million for its new fund, according to an SEC filing. Stella Kleiman and Lily Teng serve as general partners of San Francisco-based venture firm.

Modus Therapeutics rakes in funding

Stockholm-based Modus Therapeutics, which focuses on treating patients with sickle cell disease, has raised SEK 140 million (about $15.6 million) in financing. The investor was HealthCap.